GENERICally Speaking Hatch Waxman Bulletin

The Hatch-Waxman Litigation practice group at Robins Kaplan LLP is pleased to offer the latest edition of their quarterly publication regarding ANDA patent litigation issues and the generics business.

Vol. 1, No. 1

Winter 2011/2012

 Relevant court decisions highlighted in this issue:

  • Sanofi-Aventis v. Apotex Inc. 
  • Teva Pharma. Indus. Ltd. v. AstraZeneca Pharma. LP 
  • Warner Chilcott Labs. Ireland Ltd. v. Mylan Pharma. Inc. 


Oren D. Langer


Managing Partner, New York Office

Reference Listed Drug, NDA Holder, Generic Drug Name, ANDA Applicant(s), Indication and Launch Date